Related Experiment Video
Updated: Apr 25, 2026

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
Traversing the fungal terpenome
Maureen B Quin1, Christopher M Flynn, Claudia Schmidt-Dannert
1University of Minnesota, Dept. of Biochemistry, Molecular Biology and Biophysics, 1479 Gortner Avenue, St. Paul, MN 55108, USA.
Fungi produce diverse terpenoids, including sesqui-, di-, and triterpenoids. Genome mining and pathway refactoring can unlock the discovery and production of pharmaceutically valuable fungal terpenoids.
Area of Science:
- Fungal natural product biosynthesis
- Metabolic engineering
- Bioinformatics
Background:
- Fungi, particularly Ascomycota and Basidiomycota, synthesize a wide array of terpenoid compounds.
- While terpenoid biosynthesis is understood in Ascomycota, pathways in Basidiomycota remain largely uncharacterized.
- Basidiomycota produce diverse sesquiterpenoids, including trans-humulyl cation derived compounds with significant bioactivity.
Purpose of the Study:
- To explore the potential of fungal terpenoid biosynthesis for discovering new natural products.
- To investigate the application of genome sequencing and bioinformatics for identifying fungal terpenoid biosynthetic gene clusters.
- To highlight the utility of heterologous pathway refactoring for producing pharmaceutically relevant fungal terpenoids.
Main Methods:
- Genome sequencing and mining to identify biosynthetic gene clusters.
- Bioinformatic analysis to predict gene functions and pathways.
- Heterologous expression and refactoring of biosynthetic pathways in a model host.
Main Results:
- Identification of biosynthetic gene clusters for fungal terpenoids, including those derived from trans-humulyl cation.
- Demonstration of the feasibility of using genome mining to discover novel terpenoid pathways.
- Potential for heterologous production of complex fungal terpenoids.
Conclusions:
- Genome mining and bioinformatics are powerful tools for uncovering fungal terpenoid biosynthetic pathways.
- Heterologous pathway refactoring offers a viable strategy for the production of pharmaceutically important fungal terpenoids.
- Further research into Basidiomycota terpenoids promises significant discoveries for drug development.
More Related Videos
Related Concept Videos
Overview of Fungi
Fungal Phylum Basidiomycota
Fungal Group Zygomycota
Fungal Phylum Ascomycota
Fungal Phylum Microsporidia
Antifungal Agents

